Lipid metabolic vulnerabilities of multiple myeloma

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Multiple myeloma (MM) is the second most common hematological malignancy worldwide, characterized by abnormal proliferation of malignant plasma cells within a tumor-permissive bone marrow microenvironment. Metabolic dysfunctions are emerging as key determinants in the pathobiology of MM. In this review, we highlight the metabolic features of MM, showing how alterations in various lipid pathways, mainly involving fatty acids, cholesterol and sphingolipids, affect the growth, survival and drug responsiveness of MM cells, as well as their cross-talk with other cellular components of the tumor microenvironment. These findings will provide a new path to understanding the mechanisms underlying how lipid vulnerabilities may arise and affect the phenotype of malignant plasma cells, highlighting novel druggable pathways with a significant impact on the management of MM.
Funding Information
  • Associazione Italiana per la Ricerca sul Cancro,Italy (24449, 24449, 24449, 24449, 24449)
  • Università degli studi "Magna Graecia" di Catanzaro

This publication has 170 references indexed in Scilit: